Search research articles
Contact Us
Filters
Showing results (21-30 of 124) with videos related to
Page
of 13
Sort By:
British Journal of Cancer
|
February 19, 2004
Cellular responses to ionising radiation of AT heterozygotes: differences between missense and truncating mutation carriers
M Fernet, N Moullan, A Lauge, et al.
Lancet (London, England)
|
October 19, 1996
Intraductal component and BRCA1-associated breast cancer
J Jacquemler, F Eisinger, J M Guinebretiere, et al.
Cancer Research
|
March 15, 1996
Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity
E Duchaud, A Ridet, D Stoppa-Lyonnet, et al.
The New England Journal of Medicine
|
July 2, 1987
Altered C1 inhibitor genes in type I hereditary angioedema
D Stoppa-Lyonnet, M Tosi, J Laurent, et al.
Annales De Dermatologie Et De Venereologie
|
January 1, 1987
[HLA markers and complotypes: risk factors in systemic lupus erythematosus?]
A Gougerot, D Stoppa-Lyonnet, J C Poirier, et al.
Pathologie-Biologie
|
June 1, 1986
[Familial studies of systemic lupus erythematosus. HLA markers and complotypes]
D Stoppa-Lyonnet, A Gougerot, J C Poirier, et al.
JAMA
|
January 14, 2000
Acceptability of prophylactic mastectomy in cancer-prone women
F Eisinger, C Julian-Reynier, H Sobol, et al.
The Surgical Clinics of North America
|
November 26, 1999
Genetic testing for breast cancer predisposition
M Gauthier-Villars, S Gad, V Caux, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1996
Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfecta
P Beuzeboc, J Y Pierga, D Stoppa-Lyonnet, et al.
Genes, Chromosomes & Cancer
|
September 25, 2004
Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families
E Cavaciuti, A Laugé, N Janin, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 124) with videos related to
Sort By:
Page
of 13
British Journal of Cancer
|
February 19, 2004
Cellular responses to ionising radiation of AT heterozygotes: differences between missense and truncating mutation carriers
M Fernet, N Moullan, A Lauge, et al.
Lancet (London, England)
|
October 19, 1996
Intraductal component and BRCA1-associated breast cancer
J Jacquemler, F Eisinger, J M Guinebretiere, et al.
Cancer Research
|
March 15, 1996
Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity
E Duchaud, A Ridet, D Stoppa-Lyonnet, et al.
The New England Journal of Medicine
|
July 2, 1987
Altered C1 inhibitor genes in type I hereditary angioedema
D Stoppa-Lyonnet, M Tosi, J Laurent, et al.
Annales De Dermatologie Et De Venereologie
|
January 1, 1987
[HLA markers and complotypes: risk factors in systemic lupus erythematosus?]
A Gougerot, D Stoppa-Lyonnet, J C Poirier, et al.
Pathologie-Biologie
|
June 1, 1986
[Familial studies of systemic lupus erythematosus. HLA markers and complotypes]
D Stoppa-Lyonnet, A Gougerot, J C Poirier, et al.
JAMA
|
January 14, 2000
Acceptability of prophylactic mastectomy in cancer-prone women
F Eisinger, C Julian-Reynier, H Sobol, et al.
The Surgical Clinics of North America
|
November 26, 1999
Genetic testing for breast cancer predisposition
M Gauthier-Villars, S Gad, V Caux, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1996
Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfecta
P Beuzeboc, J Y Pierga, D Stoppa-Lyonnet, et al.
Genes, Chromosomes & Cancer
|
September 25, 2004
Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families
E Cavaciuti, A Laugé, N Janin, et al.
Page
of 13